GTAB.B fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Glycorex Transplantation AB engages in the research and development in the field of organ transplantation. The firm focuses mainly in kidney transplant and also in liver, heart, pancreas, lung, and stem cell transplant. Its product allows transplantation regardless of the blood types of donors and recipients. The company was founded by Kurt Gösta Ingemar Nilsson in 1996 and is headquartered in Lund, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
GTAB.B has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company